Skip to main content
RIGL logo

RIGL · Rigel Pharmaceuticals Inc · Documents

Track RIGL — free
$42.53 -0.39 (-0.91%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$800.84M
Shares
18.83M
Volume · Nov 18 304.84K Avg daily vol (3M) 252.93K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 5
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $116.88M ▼ 2.8% Net loss $25.09M Diluted EPS -$0.14
2023
Mar 7
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $120.24M ▼ 19.4% Net loss $58.57M Diluted EPS -$0.34
2022
Showing 51–100 of 155 documents
Key facts CIK 1034842 CUSIP 766559702 13F (30d) 182 filings 156 filers Visit website Investor relations